| Autor: |
Lerman JB; Division of Cardiology (J.B.L., C.B.P., R.A., A.D.D.), Duke University School of Medicine, Durham, NC.; Duke Clinical Research Institute, Durham, NC (J.B.L., D.M.G., C.L.G., A.D.D.)., Guidot DM; Duke Clinical Research Institute, Durham, NC (J.B.L., D.M.G., C.L.G., A.D.D.)., Green CL; Department of Biostatistics and Bioinformatics (C.L.G.), Duke University School of Medicine, Durham, NC.; Duke Clinical Research Institute, Durham, NC (J.B.L., D.M.G., C.L.G., A.D.D.)., Patel CB; Division of Cardiology (J.B.L., C.B.P., R.A., A.D.D.), Duke University School of Medicine, Durham, NC., Agarwal R; Division of Cardiology (J.B.L., C.B.P., R.A., A.D.D.), Duke University School of Medicine, Durham, NC., Sweitzer NK; Department of Medicine, Washington University School of Medicine, St. Louis, MO (N.K.S.)., Keenan JE; Department of Surgery (J.E.K., C.A.M., J.N.S.), Duke University School of Medicine, Durham, NC., Milano CA; Department of Surgery (J.E.K., C.A.M., J.N.S.), Duke University School of Medicine, Durham, NC., Schroder JN; Department of Surgery (J.E.K., C.A.M., J.N.S.), Duke University School of Medicine, Durham, NC., DeVore AD; Division of Cardiology (J.B.L., C.B.P., R.A., A.D.D.), Duke University School of Medicine, Durham, NC.; Duke Clinical Research Institute, Durham, NC (J.B.L., D.M.G., C.L.G., A.D.D.). |
| Abstrakt: |
Competing Interests: Disclosures Drs Milano and Schroder received research funding from TransMedics. Dr DeVore received grants/contracts from Amgen, the American Heart Association, Biofourmis, Bodyport, Cytokinetics, the National Heart, Lung, and Blood Institute, Novartis, Story Health, and Vifor Pharma; consulting fees from AbioMed, AstraZeneca, and CareDx; honoraria from AbioMed and Zoll; and travel/meeting support from Abbott. Dr DeVore is on the Data and Safety Monitoring Board/Advisory Board of Cardionomic and LivaNova and has leadership or fiduciary roles in other boards, societies, committees, or advocacy groups of Natera. The other authors report no conflicts. |
